Bevacizumab-awwb and Thromboembolic disorders
Result of checking the interaction of drug Bevacizumab-awwb and disease Thromboembolic disorders for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Venous and arterial thromboembolic events (VTE and ATE), some fatal, have been reported with the use of inhibitors of vascular endothelial growth factor receptors (VEGFR). Caution is recommended when using these agents in patients with a reported history of VTE or ATE. These agents should be discontinued in patients with serious or life-threatening VTE or ATE, including pulmonary embolism.
Generic Name: bevacizumab
Brand Name: Avastin, Mvasi
Synonyms: Bevacizumab